Dexco S.A. (BVMF:DXCO3)
Brazil · Delayed Price · Currency is BRL 5.58
-0.17 (-2.96%)
Feb 4, 2026, 6:07 PM GMT-3
Dexco Income Statement
Financials in millions BRL. Fiscal year is January - December.
Millions BRL. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 8,216 | 8,235 | 7,383 | 8,487 | 8,170 | 5,880 | |
Revenue Growth (YoY) | 1.20% | 11.53% | -13.00% | 3.87% | 38.96% | 17.32% |
Cost of Revenue | 6,305 | 6,184 | 5,675 | 6,213 | 5,430 | 4,145 |
Gross Profit | 1,911 | 2,050 | 1,708 | 2,274 | 2,740 | 1,735 |
Selling, General & Admin | 1,530 | 1,545 | 1,428 | 1,459 | 1,310 | 1,037 |
Other Operating Expenses | -50.7 | 12.44 | 11.43 | 17.85 | -400.37 | 76.3 |
Operating Expenses | 1,493 | 1,572 | 1,451 | 1,477 | 909.85 | 1,113 |
Operating Income | 418.36 | 478.35 | 257.11 | 796.76 | 1,831 | 621.24 |
Interest Expense | -848.07 | -776.81 | -765.87 | -916.07 | -306.19 | -269.29 |
Interest & Investment Income | 191.21 | 264.28 | 228.92 | 384.39 | 403.86 | 132.15 |
Earnings From Equity Investments | 141.25 | -72.9 | 279.78 | 54.59 | -68.61 | -66.62 |
Currency Exchange Gain (Loss) | -128.44 | -37.77 | -148.08 | - | - | - |
Other Non Operating Income (Expenses) | 23 | -41.76 | 166.62 | - | - | - |
EBT Excluding Unusual Items | -202.69 | -186.61 | 18.49 | 319.68 | 1,860 | 417.48 |
Merger & Restructuring Charges | -124.18 | -116.27 | -100.83 | - | - | - |
Gain (Loss) on Sale of Investments | -18.08 | -18.12 | -7.76 | - | - | - |
Gain (Loss) on Sale of Assets | 94.99 | 52.68 | 16.08 | - | - | - |
Asset Writedown | 173.65 | 526.44 | 709.45 | 597.87 | 129.44 | 117.27 |
Other Unusual Items | 86.36 | 86.36 | 115.82 | - | - | - |
Pretax Income | 10.05 | 344.47 | 751.25 | 917.55 | 1,989 | 534.75 |
Income Tax Expense | -123.65 | 170.1 | -60.02 | 152.62 | 263.38 | 80.76 |
Earnings From Continuing Operations | 133.7 | 174.38 | 811.27 | 764.92 | 1,726 | 453.98 |
Minority Interest in Earnings | -22.55 | -1.96 | -21.67 | -9.06 | -0.28 | -0.17 |
Net Income | 111.15 | 172.41 | 789.6 | 755.86 | 1,725 | 453.81 |
Net Income to Common | 111.15 | 172.41 | 789.6 | 755.86 | 1,725 | 453.81 |
Net Income Growth | -67.00% | -78.16% | 4.46% | -56.19% | 280.20% | 11.90% |
Shares Outstanding (Basic) | 906 | 905 | 905 | 915 | 776 | 935 |
Shares Outstanding (Diluted) | 909 | 908 | 908 | 918 | 781 | 942 |
Shares Change (YoY) | 0.11% | 0.05% | -1.11% | 17.59% | -17.09% | -0.20% |
EPS (Basic) | 0.12 | 0.19 | 0.87 | 0.83 | 2.22 | 0.49 |
EPS (Diluted) | 0.12 | 0.19 | 0.87 | 0.82 | 2.21 | 0.48 |
EPS Growth | -67.03% | -78.18% | 5.63% | -62.74% | 358.55% | 12.12% |
Free Cash Flow | 6.65 | -44.88 | 177.26 | -354.23 | 910.96 | 1,075 |
Free Cash Flow Per Share | 0.01 | -0.05 | 0.20 | -0.39 | 1.17 | 1.14 |
Dividend Per Share | - | - | 0.192 | - | 0.945 | 0.232 |
Dividend Growth | - | - | - | - | 307.33% | -15.79% |
Gross Margin | 23.26% | 24.90% | 23.13% | 26.79% | 33.54% | 29.50% |
Operating Margin | 5.09% | 5.81% | 3.48% | 9.39% | 22.41% | 10.57% |
Profit Margin | 1.35% | 2.09% | 10.69% | 8.91% | 21.12% | 7.72% |
Free Cash Flow Margin | 0.08% | -0.55% | 2.40% | -4.17% | 11.15% | 18.27% |
EBITDA | 1,487 | 1,602 | 1,309 | 1,642 | 2,543 | 1,242 |
EBITDA Margin | 18.10% | 19.45% | 17.73% | 19.35% | 31.12% | 21.12% |
D&A For EBITDA | 1,069 | 1,123 | 1,052 | 845.45 | 712.29 | 620.51 |
EBIT | 418.36 | 478.35 | 257.11 | 796.76 | 1,831 | 621.24 |
EBIT Margin | 5.09% | 5.81% | 3.48% | 9.39% | 22.41% | 10.57% |
Effective Tax Rate | - | 49.38% | - | 16.63% | 13.24% | 15.10% |
Advertising Expenses | - | 187.75 | 150.59 | - | - | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.